[Chinese expert consensus on the diagnosis and treatment of CD5-positive diffuse large B-cell lymphoma (2026)]
{{output}}
CD5-positive diffuse large B-cell lymphoma (CD5(+) DLBCL) is a rare immunophenotypic subtype of DLBCL, typically characterized by high aggressiveness, rapid disease progression, and poor prognosis. Even in the era of rituximab-based immunochemotherapy, surviva... ...
